Overview

A Novel Approach for Alleviating the Side Effects of Chemotherapeutic Agents.

Status:
Active, not recruiting
Trial end date:
2022-01-30
Target enrollment:
Participant gender:
Summary
This study will assess the effectiveness of a natural nutraceutical in treating the known side effects of chemotherapeutic agents in cancer patients.
Phase:
Phase 2
Details
Lead Sponsor:
Optimal Health Research
Treatments:
Antineoplastic Agents
Cisplatin
Docetaxel